Special Organic Colloquium – Prof. Herman O. Sintim
Novel chemotypes of kinase inhibitors for the potential treatment of recurrent cancers Abstract: Therapeutic resistance remains a critical issue in cancer treatment. While cancer patients who harbor dysregulated protein kinases […]